Enzyme-responsive vitamin D-based micelles for paclitaxel-controlled delivery and synergistic pancreatic cancer therapy
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most feared diseases worldwide owing to its poor prognosis, negligible therapeutic advances, and high mortality. Herein, multifunctional enzyme-responsive micelles for the controlled delivery of paclitaxel (PTX) were prepared to circumvent i...
Saved in:
Main Authors: | Diana Peixoto, João M. Ravasco, Barbara Blanco-Fernandez, Francisco Veiga, Angel Concheiro, João Conde, Ana Cláudia Paiva-Santos, Carmen Alvarez-Lorenzo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-04-01
|
Series: | Materials Today Bio |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590006425001139 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of Spray-Dried Micelles, Liposomes, and Solid Lipid Nanoparticles for Enhanced Stability
by: Shradha Dattani, et al.
Published: (2025-01-01) -
Peptide Aptamer–Paclitaxel Conjugates for Tumor Targeted Therapy
by: Xinyang Shen, et al.
Published: (2024-12-01) -
Survival benefits of adjuvant chemotherapy after conversion surgery in patients with advanced pancreatic cancer
by: Yoon Suk Lee, et al.
Published: (2025-01-01) -
Paclitaxel-induced Hypersensitivity Reaction
by: Cyril Sajan, et al.
Published: (2024-12-01) -
Neoadjuvant pembrolizumab-carboplatin-paclitaxel in locally advanced squamous cell carcinoma of the oral cavity: A case report and literature review
by: Abdulrahman Hesham, et al.
Published: (2024-09-01)